Experimental immune cell treatment tested for Tough-to-Treat cancers
NCT ID NCT07274449
Summary
This early-stage study is testing whether modified immune cells called memory NK cells, when given alongside standard cancer treatments, are safe and might help control advanced solid tumors that have spread. The trial will first enroll 6 patients with cancers like colorectal, lung, or ovarian cancer that have worsened despite standard therapy. Researchers will monitor patients closely for side effects and see if the treatment shows any signs of slowing the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID CANCERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nanjing Drum Tower Hospital Affiliated to Medical School of Nanjing University
Nanjing, Jiangsu, 210008, China
Conditions
Explore the condition pages connected to this study.